The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
119833922 11983392 2 F 2010 20160715 20160201 20160726 EXP BR-ABBVIE-16K-020-1545845-00 ABBVIE 56.97 YR F Y 69.00000 KG 20160726 CN COUNTRY NOT SPECIFIED BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
119833922 11983392 1 PS HUMIRA ADALIMUMAB 1 Subcutaneous Y 51072XH01 125057 40 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
119833922 11983392 2 SS HUMIRA ADALIMUMAB 1 Subcutaneous Y 51072XH01 125057 40 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
119833922 11983392 3 C SULFASALAZINE. SULFASALAZINE 1 Oral 0 TABLET
119833922 11983392 4 C PREDNISONE. PREDNISONE 1 Oral 0 TABLET
119833922 11983392 5 C SIMVASTATIN. SIMVASTATIN 1 Oral 0 TABLET
119833922 11983392 6 C PROPRANOLOL PROPRANOLOLPROPRANOLOL HYDROCHLORIDE 1 Oral 0 TABLET
119833922 11983392 7 C INDAPAMIDE. INDAPAMIDE 1 Oral 0 TABLET
119833922 11983392 8 C AMITRIPTYLINE AMITRIPTYLINE 1 Oral 0 TABLET
119833922 11983392 9 C DIAZEPAM. DIAZEPAM 1 Oral 0 TABLET
119833922 11983392 10 C VITAMIN D/CALCIUM CALCIUMVITAMIN D 1 Oral 0 TABLET
119833922 11983392 11 C ALENDRONATE ALENDRONATE SODIUM 1 Oral 0 1 DF TABLET /wk
119833922 11983392 12 C OMEPRAZOLE. OMEPRAZOLE 1 Oral 0 TABLET
119833922 11983392 13 C CODEINE CODEINE 1 Oral 0 TABLET
119833922 11983392 14 C CODEINE CODEINE 1 Oral 0 TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
119833922 11983392 1 Rheumatoid arthritis
119833922 11983392 3 Rheumatic disorder
119833922 11983392 4 Pain
119833922 11983392 5 Blood cholesterol abnormal
119833922 11983392 6 Hypertension
119833922 11983392 7 Hypertension
119833922 11983392 8 Fibromyalgia
119833922 11983392 9 Pain
119833922 11983392 10 Bone disorder
119833922 11983392 11 Bone disorder
119833922 11983392 12 Gastric disorder
119833922 11983392 13 Spinal disorder

Outcome of event

Event ID CASEID OUTC COD
119833922 11983392 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
119833922 11983392 Bone pain
119833922 11983392 Fall
119833922 11983392 Sinusitis
119833922 11983392 Spinal osteoarthritis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
119833922 11983392 1 20090101 20151221 0
119833922 11983392 3 2005 0
119833922 11983392 4 1999 0
119833922 11983392 5 2010 0
119833922 11983392 8 2008 0
119833922 11983392 9 2008 201605 0
119833922 11983392 10 2004 0
119833922 11983392 11 2004 0
119833922 11983392 13 201410 0
119833922 11983392 14 201504 201606 0